These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 22762732

  • 1. Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice.
    Mitra S, Barman S, Nag D, Sinha R, Saha DR, Koley H.
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):240-50. PubMed ID: 22762732
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain.
    Mitra S, Sinha R, Mitobe J, Koley H.
    Vaccine; 2016 Apr 04; 34(15):1839-46. PubMed ID: 26878295
    [Abstract] [Full Text] [Related]

  • 5. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice.
    Camacho AI, de Souza J, Sánchez-Gómez S, Pardo-Ros M, Irache JM, Gamazo C.
    Vaccine; 2011 Oct 26; 29(46):8222-9. PubMed ID: 21911022
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice.
    Bhaumik U, Halder P, Howlader DR, Banerjee S, Maiti S, Dutta S, Koley H.
    Microbes Infect; 2023 Jun 26; 25(5):105100. PubMed ID: 36696935
    [Abstract] [Full Text] [Related]

  • 8. Outer Membrane Vesicles Derived from Salmonella enterica Serotype Typhimurium Can Deliver Shigella flexneri 2a O-Polysaccharide Antigen To Prevent Shigella flexneri 2a Infection in Mice.
    Tian H, Li B, Xu T, Yu H, Chen J, Yu H, Li S, Zeng L, Huang X, Liu Q.
    Appl Environ Microbiol; 2021 Sep 10; 87(19):e0096821. PubMed ID: 34319809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccine potential for inactivated shigellae.
    Osorio M, Bray MD, Walker RI.
    Vaccine; 2007 Feb 19; 25(9):1581-92. PubMed ID: 17178431
    [Abstract] [Full Text] [Related]

  • 13. Development of a new guinea-pig model of shigellosis.
    Barman S, Saha DR, Ramamurthy T, Koley H.
    FEMS Immunol Med Microbiol; 2011 Aug 19; 62(3):304-14. PubMed ID: 21539623
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Etiological factors in bacillary dysentery in Poland 1965-1979].
    Stypułkowska-Misiurewicz H, Adonajło A.
    Przegl Epidemiol; 1981 Aug 19; 35(4):443-53. PubMed ID: 7041196
    [No Abstract] [Full Text] [Related]

  • 17. Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.
    Orr N, Robin G, Cohen D, Arnon R, Lowell GH.
    Infect Immun; 1993 Jun 19; 61(6):2390-5. PubMed ID: 8500877
    [Abstract] [Full Text] [Related]

  • 18. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.
    Clarkson KA, Porter CK, Talaat KR, Frenck RW, Alaimo C, Martin P, Bourgeois AL, Kaminski RW.
    mSphere; 2021 Aug 25; 6(4):e0012221. PubMed ID: 34259559
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS, Kaur G, Sivaramakrishna U, Singh D, Bansal A.
    Vaccine; 2016 Oct 17; 34(44):5376-5383. PubMed ID: 27591952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.